Wade R. Gutierrez

495 total citations
18 papers, 206 citations indexed

About

Wade R. Gutierrez is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wade R. Gutierrez has authored 18 papers receiving a total of 206 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wade R. Gutierrez's work include CAR-T cell therapy research (5 papers), Sarcoma Diagnosis and Treatment (5 papers) and CRISPR and Genetic Engineering (4 papers). Wade R. Gutierrez is often cited by papers focused on CAR-T cell therapy research (5 papers), Sarcoma Diagnosis and Treatment (5 papers) and CRISPR and Genetic Engineering (4 papers). Wade R. Gutierrez collaborates with scholars based in United States, Russia and France. Wade R. Gutierrez's co-authors include Rebecca D. Dodd, Vickie Knepper-Adrian, Douglas M. Bennion, Jarrett Walsh, Mei-ling A. Joiner, Teresa Puthussery, Sajag Bhattarai, Jussara Hagen, Paloma H. Giangrande and Nikolai O. Artemyev and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Wade R. Gutierrez

16 papers receiving 204 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wade R. Gutierrez United States 8 132 47 35 33 28 18 206
Sho Tamai Japan 10 93 0.7× 26 0.6× 27 0.8× 43 1.3× 55 2.0× 25 237
Małgorzata Kurkowiak Poland 8 121 0.9× 21 0.4× 61 1.7× 48 1.5× 30 1.1× 13 253
Kyle S. Yau Australia 7 145 1.1× 27 0.6× 17 0.5× 32 1.0× 25 0.9× 10 250
Zhenfu Zhao China 9 154 1.2× 39 0.8× 18 0.5× 17 0.5× 74 2.6× 21 274
Yasuyoshi Chiba Japan 9 80 0.6× 20 0.4× 31 0.9× 65 2.0× 27 1.0× 25 301
Roni Blatt United States 4 54 0.4× 48 1.0× 27 0.8× 28 0.8× 11 0.4× 10 239
Jamie Mong Singapore 8 193 1.5× 36 0.8× 36 1.0× 77 2.3× 54 1.9× 11 309
Kelly Arndt United States 10 255 1.9× 38 0.8× 8 0.2× 43 1.3× 40 1.4× 17 378
Verónica Casquero-García Spain 5 188 1.4× 13 0.3× 18 0.5× 23 0.7× 38 1.4× 7 249

Countries citing papers authored by Wade R. Gutierrez

Since Specialization
Citations

This map shows the geographic impact of Wade R. Gutierrez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wade R. Gutierrez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wade R. Gutierrez more than expected).

Fields of papers citing papers by Wade R. Gutierrez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wade R. Gutierrez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wade R. Gutierrez. The network helps show where Wade R. Gutierrez may publish in the future.

Co-authorship network of co-authors of Wade R. Gutierrez

This figure shows the co-authorship network connecting the top 25 collaborators of Wade R. Gutierrez. A scholar is included among the top collaborators of Wade R. Gutierrez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wade R. Gutierrez. Wade R. Gutierrez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Borcherding, Nicholas, Adam J. Rauckhorst, Wade R. Gutierrez, et al.. (2025). Somatic CRISPR tumorigenesis and multiomic analysis reveal a pentose phosphate pathway disruption vulnerability in MPNSTs. Science Advances. 11(33). eadu2906–eadu2906.
2.
3.
Gutierrez, Wade R., et al.. (2024). Variability in Methodology of Erectile Dysfunction Regenerative Therapy Trials on ClinicalTrials.gov. Urology. 189. 135–143. 1 indexed citations
4.
Gutierrez, Wade R., et al.. (2023). Discrepancies in indel software resolution with somatic CRISPR/Cas9 tumorigenesis models. Scientific Reports. 13(1). 14798–14798. 2 indexed citations
5.
Gutierrez, Wade R., et al.. (2023). Loss of Nf1 and Ink4a/Arf Are Associated with Sex-Dependent Growth Differences in a Mouse Model of Embryonal Rhabdomyosarcoma. Current Issues in Molecular Biology. 45(2). 1218–1232. 3 indexed citations
6.
Gutierrez, Wade R., Vickie Knepper-Adrian, Dawn E. Quelle, et al.. (2022). Augmenting chemotherapy with low-dose decitabine through an immune-independent mechanism. JCI Insight. 7(22). 7 indexed citations
7.
Gutierrez, Wade R., Andrew P. Voigt, Vickie Knepper-Adrian, et al.. (2022). PRC2 loss drives MPNST metastasis and matrix remodeling. JCI Insight. 7(20). 11 indexed citations
8.
Gutierrez, Wade R., et al.. (2021). Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor models. Scientific Reports. 11(1). 1098–1098. 8 indexed citations
9.
Dodd, Rebecca D., Wesley Huang, Wade R. Gutierrez, et al.. (2020). Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle–based Chemotherapy in Pten -deleted Mouse Models of Sarcoma. Clinical Cancer Research. 26(18). 5036–5047. 7 indexed citations
10.
Monga, Varun, Rebecca D. Dodd, Wade R. Gutierrez, et al.. (2020). Phase Ib study of decitabine in combination with gemcitabine in treatment of advanced soft tissue and bone sarcomas.. Journal of Clinical Oncology. 38(15_suppl). 11550–11550. 7 indexed citations
11.
Moose, Devon L., Wade R. Gutierrez, Robert Svensson, et al.. (2020). Locally invasive, castrate-resistant prostate cancer in a Pten/Trp53 double knockout mouse model of prostate cancer monitored with non-invasive bioluminescent imaging. PLoS ONE. 15(9). e0232807–e0232807. 5 indexed citations
12.
Gutierrez, Wade R., et al.. (2020). Vascular pedicled flaps for skull base defect reconstruction. Laryngoscope Investigative Otolaryngology. 5(6). 1029–1038. 17 indexed citations
13.
Gutierrez, Wade R., et al.. (2020). Distinct Tumor Microenvironments Are a Defining Feature of Strain-Specific CRISPR/Cas9-Induced MPNSTs. Genes. 11(5). 583–583. 11 indexed citations
14.
Lin, Li‐Hsien, Justin P. Dassie, William H. Thiel, et al.. (2019). RNA inhibitors of nuclear proteins responsible for multiple organ dysfunction syndrome. Nature Communications. 10(1). 116–116. 17 indexed citations
15.
Kerov, Vasily, Joseph G. Laird, Mei-ling A. Joiner, et al.. (2018). α 2 δ-4 Is Required for the Molecular and Structural Organization of Rod and Cone Photoreceptor Synapses. Journal of Neuroscience. 38(27). 6145–6160. 52 indexed citations
16.
Kruspe, Sven, David D. Dickey, Matthew J. Miller, et al.. (2017). Rapid and Sensitive Detection of Breast Cancer Cells in Patient Blood with Nuclease-Activated Probe Technology. Molecular Therapy — Nucleic Acids. 8. 542–557. 31 indexed citations
17.
Kumar, Dhruv, Vikalp Vishwakarma, Jacob New, et al.. (2016). Abstract B37: Targeting tumor-stroma metabolic symbiosis for head and neck cancer therapy. Cancer Research. 76(15_Supplement). B37–B37. 1 indexed citations
18.
Hiraishi, Hiroyuki, Sherry L. Haller, Evangelos Papadopoulos, et al.. (2014). Essential role of eIF5-mimic protein in animal development is linked to control of ATF4 expression. Nucleic Acids Research. 42(16). 10321–10330. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026